Key result
Heterozygous familial hypercholesterolemia fibroblasts exhibit ~50% fewer LDL receptors, impairing intracellular cholesterol regulation.
Answers are grounded in this paper and cite their sources.
Demonstrates that LDL receptor deficiency impairs cholesterol suppression and lipoprotein degradation in familial hypercholesterolemia, highlighting a key regulatory feedback mechanism.
Analysis of mutant human fibroblasts deficient in a cell surface receptor for low density lipoproteins (LDL) has led to the delineation of an important, hitherto unrecognized, regulatory process for cholesterol metabolism. On normal cells, binding of LDL to this receptor regulates cholesterol metabolism by two mechanisms: (a) suppression of cholesterol synthesis and (b) facilitation of the rate of proteolytic degradation of the lipoprotein. In cells from homozygotes with the autosomal dominant disorder Familial Hypercholesterolemia, a nearly total reduction in LDL receptors results in two secondary abnormalities: (a) overproduction of cholesterol due to an inability of LDL to suppress the activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase, the rate-controlling enzyme in cholesterol biosynthesis, and (b) impairment in the rate of proteolytic degradation of LDL. Cells from heterozygotes possess about 50 per cent of the normal number of LDL recpetors; this leads to a concentration-dependent defect in regulation, so that attainment of rates of cholesterol synthesis and LDL degradation equal to that in normal cells requires a two to three-fold higher concentration of extracellular LDL in the heterozygote. The identification of this genetic regulatory defect in fibroblasts of heterozygotes with Familial Hypercholesterolemia makes available an in vitro system for studying the molecular mechanism by which a dominant mutation affects gene expression in mammalian cells.
No takes yet. Share an insight, caveat, or question.
Brown et al. (1975) studied Familial Hypercholesterolemia. LDL receptor deficiency in Familial Hypercholesterolemia fibroblasts vs. Normal human fibroblasts was evaluated on Number of cell surface LDL receptors and regulation of cholesterol synthesis and LDL proteolytic degradation. Fibroblasts from Familial Hypercholesterolemia heterozygotes have ~50% of normal LDL receptors, requiring 2- to 3-fold higher extracellular LDL for normal cholesterol regulation.
Synapse has enriched 10 related papers. Consider them for comparative context: